AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

SurModics Grows Its Client List; Selling Its Coatings To J&J, Other Stent Makers.(THE IBD 100)

Investor's Business Daily

| May 02, 2005 | COPYRIGHT 2005 Investor's Business Daily, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: Jonah Keri

In the medical field, finding the right niche can prove hugely profitable. SurModics is living proof.

The Eden Prairie, Minn.-based firm makes coatings used for an array of medical devices, including catheters and pacemakers. The firm gets the biggest chunk of its revenue from drug-eluting stents.

About half of SurModics' total sales come from Johnson & Johnson -- a curse and a blessing for the firm. SurModics' artery-clearing Cypher stents have helped J&J grab market share away from Boston Scientific. Meanwhile, SurModics has achieved steady growth, hiking earnings by 24% or more in eight of the last nine quarters.

Relying too much on one customer can come back to burn a company. To that end, SurModics has cultivated relationships with other clients. It provides coatings used in Foxhollow Technologies' Silverhawk plaque excision system, for one. The percentage of revenue that J&J provides for ...

Related articles from newspapers, magazines, journals, and more
Solid Profit Margins Help Buoy SurModics.(B)(NASDAQ STOCKS IN THE NEWS)
Magazine article from: Investor's Business Daily October 11, 2005 700+ words
Byline: Christina Wise SurModics notched a 52-week high June...pacemakers, stents and catheters. SurModics' return on equity has improved...6% in 2004. The firm's sales growth has been accelerating for...polled by First Call expect SurModics' earnings growth to slow...
Zacks Analyst Blog Highlights: Companhia Energetica de Minas Gerais, SurModics,...
Press release article from: Business Wire November 12, 2008 700+ words
...Minas Gerais (NYSE: CIG), SurModics, Inc. (Nasdaq: SRDX...an attractive valuation. SurModics Trades Near Fair Value SurModics, Inc. (Nasdaq: SRDX...strategy to achieve profitable sales growth over the long term. Its strategy...
SurModics Acquires Drug Delivery Assets of PR Pharmaceuticals.
Press release article from: Business Wire November 4, 2008 700+ words
...Development Programs EDEN PRAIRIE, Minn. -- SurModics, Inc. (Nasdaq: SRDX), a leading...biodegradable sustained release formulations. SurModics paid $3 million in cash at closing and...acquisition is expected to be accretive to SurModics' fiscal 2009 earnings, excluding any...
SurModics Collaborates with CardioMind on Drug Eluting Stent Development.
Press release article from: Business Wire July 12, 2005 700+ words
...Minn. & SUNNYVALE, Calif. -- SurModics, Inc. (Nasdaq:SRDX) and CardioMind...into a license agreement for the use of SurModics' ENCORE(TM) Drug Delivery Polymer...President and Chief Executive Officer of SurModics commented, "SurModics is pleased to...
SurModics Gains Access to Biodegradable Polymer Technology for Site Specific...
Press release article from: Business Wire March 6, 2006 700+ words
EDEN PRAIRIE, Minn. -- SurModics, Inc. (Nasdaq:SRDX), a leading provider...drug delivery arena remains a key goal for SurModics," said Bruce Barclay, President and CEO of SurModics. "Our customers continue to express strong...
SurModics Expands In Vitro Diagnostics Product Offerings; Obtains Rights to New...
Press release article from: Business Wire July 18, 2006 700+ words
EDEN PRAIRIE, Minn. -- SurModics, Inc. (Nasdaq:SRDX), a leading...DIARECT AG. Under this new agreement, SurModics will distribute DIARECT's recombinant...currently the exclusive distributor for SurModics' manufactured stabilization products...
SurModics Makes Strategic Investment in ThermopeutiX; SurModics Also Licenses...
Press release article from: Business Wire May 24, 2005 700+ words
EDEN PRAIRIE, Minn. -- SurModics, Inc. (Nasdaq:SRDX), a leading...In addition to the investment, SurModics has licensed its hydrophilic and...Bruce Barclay, President and COO of SurModics. "In addition to our investment...
SurModics to Present Five Posters at the Association for Research in Vision and...
Press release article from: Business Wire May 3, 2007 700+ words
EDEN PRAIRIE, Minn. -- SurModics, Inc. (Nasdaq: SRDX), a leading provider...platform technologies currently under development at SurModics. "ARVO is an important meeting for SurModics, and we are pleased to showcase our scientific...
SurModics teams with Merck on retinal drug delivery tech.
Magazine article from: Medical Device Week June 28, 2007 700+ words
SurModics teams with Merck on retinal drug delivery...FORD Medical Device Daily Staff Writer SurModics (Eden Prairie, Minnesota) and Merck...from Merck with the I-vation system. SurModics will receive an up-front licensing...
SurModics acquires remaining portion of InnoRx for $4.1M.
Magazine article from: Medical Device Week January 20, 2005 700+ words
SurModics acquires remaining portion of InnoRx...Medical Device Daily Managing Editor SurModics (Eden Prairie, Minnesota), a provider...ophthalmology. Prior to the acquisition, SurModics held an ownership interest in InnoRx...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA